@article {1429, title = {Fenugreek (Trigonella Foenum-Graecum) and its Active Compounds: A Review of its Effects on Human Health through Modulating Biological Activities}, journal = {Pharmacognosy Journal}, volume = {13}, year = {2021}, month = {May 2021}, pages = {813-821}, type = {Review Article}, chapter = {813}, abstract = {

Fenugreek seed are rich sources of various essential compounds and such components shows a significant role in the diseases cure and management through its anti-inflammatory, hepatoprotective, cardioprotective, neuroprotective, immunomodulatory, nephroprotective and anti-microbial activity. Moreover, fenugreek seed is a rich source of antioxidant and such potentiality inhibit the pathogenesis of diseases through free radical scavenging activity. Besides, fenugreek and its active compound shows role in tumour inhibition through modulating various genes activity including induction of apoptosis, tumour suppressor gene and inhibition of tumor necrosis factor. This review comprehensively summarizes the role of fenugreek seeds in health management through modulating various physiological and biochemical activities, along with special emphasis on in vitro and in vivo study.

}, keywords = {Anti-cancer activity, Anti-inflammatory, Anti-oxidant, Fenugreek, Health management, Trigonella foenum-graecum}, doi = {10.5530/pj.2021.13.103}, author = {Saleh A Almatroodi and Ahmad Almatroudi and Mohammed A Alsahli and Arshad Husain Rahmani} } @article {1267, title = {Encouraging Leads from Marine Sources for Cancer Therapy A Review Approach}, journal = {Pharmacognosy Journal}, volume = {12}, year = {2020}, month = {September 2020}, pages = {1475-1481}, type = {Review Article}, chapter = {1475}, abstract = {

Cancer is one of the dreadful illnesses that cause mortality in many individuals around the world. Present cancer treatments generally include surgery, radiation therapy with chemotherapy. One of the primary sources of anticancer drugs are natural products that exhibit impressive potential in medicines. Plant and microbial secondary metabolites are an important source for cancer drug development. The ocean has an immense collection of flora and fauna overflowing with natural compounds having potent pharmaceutical significance. Marine bioprospecting has just started recently hence, marine ecosystem has not yet been explored properly. Nearly 68 percent of the drugs derived from marine sources are utilized for cancer and the remaining are utilized for inflammation, pain relief etc. Ongoing advancement in synthetic processes has helped in solving the limitations caused due to the complicated structure of natural products. Unlimited potent sources of compounds that can be isolated having diverse structures are found in the marine biodiversity. Only 1\% of the marine microorganisms have been distinguished till now. Coral reefs and mangrove ecosystem have been focused for bioprospecting on the grounds that they have an elevated level of biodiversity. This review focuses on pharmacologically active anti-cancer lead discovery from marine ecosystem. The review has also tried to describe the structure

}, keywords = {Algae, Anti-cancer activity, Marine sponges, Natural sources}, doi = {10.5530/pj.2020.12.202}, author = {N Srinivasan and S Dhanalakshmi and P Pandian} } @article {351, title = {An examination of the Antimicrobial and Anticancer Properties of Khaya senegalensis (Desr.) A. Juss. Bark Extracts}, journal = {Pharmacognosy Journal}, volume = {9}, year = {2017}, month = {May 2017}, pages = {504-518}, type = {Original Article}, chapter = {504}, abstract = {

Background: Khaya senegalensis (Desr.) A. Juss. is a common component of the pharmacopeia\’s of multiple African groupings which inhabit the areas in which it grows. Amongst these groups there is a myriad of medicinal uses in the treatment of a wide variety of bacterial, fungal and protozoal infections, as well as in the treatment of cancers. This study was undertaken to test K. senegalensis bark extracts for the ability to inhibit microbial and cancer cell growth, and thus to validate traditional African medicinal usage of this plant in treating a variety of diseases. Materials and Methods: K. senegalensis bark powder was extracted by both solvent maceration and subcritical fluid extraction (SFE). The extracts were tested for the ability to inhibit bacterial and G. duodenalis growth. Inhibition of Caco-2 and HeLa cancer cells was evaluated using MTS-based colorimetric cell proliferation assays. Toxicity was evaluated using an Artemia franciscana nauplii bioassay and GC-MS headspace analysis was used to identify phytochemical components. Results: K. senegalensis bark extracts displayed strong inhibitory activity against bacterial triggers of several autoimmune inflammatory diseases. The growth inhibitory activity of the methanolic and subcritical extracts was particularly noteworthy against P. mirabilis (MIC values of 185 and 211\μg/mL, respectively against the reference strains). These extracts were similarly potent growth inhibitors of K. pneumoniae and A. baylyi\ and were moderate inhibitors (MIC \>1000\μg/mL) of P. aeruginosa and S. pyogenes growth. The methanolic and subcritical K. senegalensis extracts were also potent inhibitors of G. duodenalis (187 and 328\μg/mL, respectively), as well as Caco-2 (268 and 470\μg/mL, respectively) and HeLa carcinomas (155 and 174\μg/mL, respectively). GC-MS analysis of the SFE extract revealed relative abundances of a variety of mono- and sesquiterpenoids. Furthermore, all K. senegalensis bark extracts were non-toxic in the Artemia franciscana toxicity assay, indicating their safety for therapeutic use. Conclusion: These studies validate traditional African therapeutic usage of K. senegalensis in the treatment of microbial infections, autoimmune inflammatory diseases and some cancers.

}, keywords = {African mahogany, Anti bacterial activity, Anti-cancer activity, Anti-proliferative activity, Giardia duodenalis, Meliaceae, Sub-critical fluid extraction, Terpenoid.}, doi = {10.5530/pj.2017.4.82}, url = {/files/PJ-9-4/10.5530pj.2017.4.82}, author = {Camille Rabadeaux and Lou Vallette and Joseph Sirdaarta and Craig Davis and Ian Edwin Cock} }